A panel discussion from the Australian Academy of Health and Medical Sciences 2022 Annual Meeting on developing transformative health technologies in Australia – cultivating innovation and entrepreneurship.
Chair: Prof Andrew Wilks FTSE FAHMS, Executive Chair at SYNthesis med chem, CEO at SYNthesis Research, CEO at Catalyst Tx
- Dr Anne-Laure Puaux, Head, Biotechnology and Commercialisation, WEHI
- Dr Michael Bettess, Senior Investment Manager, Brandon Capital
- Professor Bronwyn Kingwell FAHMS, Senior Director, Research Therapeutics Area Lead, CSL Limited
- Professor David Winkler, Professor of Medicinal Chemistry, Monash University